| NYSE Euronext Announces Trading Volumes for July 2012 |
|
09/08/2012 06:55 (289 Day 11:18 minutes ago) | |||||
|
The FINANCIAL -- NYSE Euronext global derivatives ADV in July 2012 of 7.0 million contracts decreased 12.0% compared to July 2011 and decreased 15.8% from June 2012 levels.
NYSE Euronext European derivatives products ADV in July 2012 of 3.5 million contracts decreased 6.8% compared to July 2011 and decreased 24.7% from June 2012.
Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 9.9% compared to July 2011 and decreased 8.5% from June 2012 levels. NYSE Euronext U.S. equity options ADV of 3.5 million contracts in July 2012 decreased 15.8% compared to July 2011 levels and decreased 3.8% from June 2012.
NYSE Euronext’s U.S. options exchanges accounted for 25.9% of total U.S. consolidated equity options trading in July 2012, up from 25.8% in July 2011 and up from 25.6% in June 2012.
NYSE Liffe U.S. ADV of approximately 53,400 contracts decreased from 101,300 contracts in July 2011 and decreased from 90,900 contracts in June 2012.
NYSE Euronext European cash products ADV of 1.5 million transactions in July 2012 decreased 10.8% compared to July 2011 and decreased 12.3% from June 2012 levels.
As NYSE Euronext reported, its U.S. cash products handled ADV of 1.7 billion shares in July 2012 decreased 16.9% compared to July 2011 and decreased 9.9% compared to June 2012. NYSE Euronext’s Tape A matched market share in July 2012 was 32.1%, down from 34.3% in July 2011 and down from 32.3% in June 2012.
NYSE Euronext European derivatives products ADV in July 2012 of 3.5 million contracts decreased 6.8% compared to July 2011 and decreased 24.7% from June 2012 levels.
The 3.5 million in European derivatives futures and options contracts ADV in July 2012 consisted of 2.7 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.8 million contracts, or 23.8%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 9.9% compared to July 2011 and decreased 8.5% compared to June 2012.
Total fixed income products ADV of 1.8 million contracts in July 2012 decreased 4.2% from July 2011 and decreased 6.4% from June 2012. Year-to-date, total fixed income products ADV of 1.9 million contracts was 21.1% below prior year levels. Total equity products (including Bclear) ADV of 1.5 million contracts in July 2012 decreased 12.1% compared to July 2011 and decreased 40.6% from June 2012.
The 1.5 million contracts in equity products ADV in July 2012 consisted of 1.1 million contracts in individual equity products ADV and 0.4 million contracts in equity index products ADV.
The 1.1 million contracts in individual equity products ADV consisted of 0.7 million in futures contracts, which represented a 4.0% increase compared to July 2011 and 0.4 million in options contracts, which represented a 21.5% decrease compared to July 2011.
The average net rate per contract for individual equity futures contracts is significantly lower than other European derivatives products. Year-to-date, total equity products ADV of 2.0 million contracts was 16.3% below prior year levels.
Total commodities products ADV of approximately 119,000 contracts in July 2012 increased 52.2% compared to July 2011 and increased 45.5% compared to June 2012. Year-to-date, total commodities product ADV of 86,000 contracts was 0.7% above prior year levels.
Total U.S. consolidated equity options ADV decreased 16.1% to 13.5 million contracts in July 2012 compared to July 2011 and decreased 5.1% compared to June 2012. Year-to-date, U.S. consolidated equity options ADV of 15.1 million contracts was 8.2% below prior year levels.
NYSE Euronext’s U.S. options exchanges accounted for 25.9% of total U.S. consolidated equity options trading in July 2012, up from 25.8% in July 2011 and up from 25.6% in June 2012.
NYSE Euronext European cash products ADV of 1.5 million transactions in July 2012 decreased 10.8% compared to July 2011 and decreased 12.3% compared to June 2012.
Year-to-date, European cash products ADV of 1.6 million transactions was 3.0% below prior year levels.
Year-to-date, U.S. cash products handled ADV was 1.8 billion shares, down 17.8% from prior year levels.
NYSE Euronext’s Tape A matched market share in July 2012 was 32.1%, down from 34.3% in July 2011 and down from 32.3% in June 2012. Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 225 million shares was 19.7% below prior year levels.
|
|
|
